The AEMPS (Spanish Drug and Healthcare Products Agency) granted Medical Plants SLU, (a division of a major Spanish tomato producer), authorization to cultivate, process, and manufacture cannabis in September of 2020. Medical Plants SLU will operate under a Good Manufacturing Practices (GMP) certification for the cultivation of cannabis for use in clinical trials and research
The granting of these licences allows for applications to be made by non-relate dparties for
similar
purpose;
The BudzCorp business model allows for the cultivation of marijuana for; export, research
and/or
medicinal purposes;
Applications are being made to the Narcotics and Psychotropic Department of the AEMPS;
BudzCorp is committed to the annual reporting guidelines and parameters of operation,
cultivation
and processing as set down by AEMS;
Licenses are a duration of one year and must be renewed annually
BudzCorp has provided for the costs attached to holding the imprimatur of a research
institution or
clinical trial body.
BudzCorp is seeking similar licensing in other European jurisdictions including – but not
restricted to;
• Portugal
• Germany